Affordable Access

deepdyve-link deepdyve-link
Publisher Website

C-reactive protein lowering with rosuvastatin in the METEOR study.

Authors
  • Peters, S A E1
  • Palmer, M K
  • Grobbee, D E
  • Crouse, J R 3rd
  • O'Leary, D H
  • Raichlen, J S
  • Bots, M L
  • 1 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. [email protected] , (Netherlands)
Type
Published Article
Journal
Journal of internal medicine
Publication Date
Aug 01, 2010
Volume
268
Issue
2
Pages
155–161
Identifiers
DOI: 10.1111/j.1365-2796.2010.02230.x
PMID: 20412373
Source
Medline
License
Unknown

Abstract

Rosuvastatin (40 mg) lowers CRP independently from its effects on LDL-C in low-risk subjects with normal baseline CRP levels and modest CIMT.

Report this publication

Statistics

Seen <100 times